Item 5. Other Events
On January 5, 2004, Generex Biotechnology Corporation issued a press release announcing that Generex raised $2,500,000 in a private placement of Units containing common stock and warrants. Under the terms of the transaction, Generex issued Units containing an aggregate 1,700,680 shares of common stock and warrants exercisable for 425,170 shares to 3 investors. The investors have the right to purchase an equal number of Units at the same price exercisable until 60 days after effectiveness of the registration statement covering resale of the shares in the initial Units. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
|
(c) Exhibits |
|
|
|
|
|
Exhibit No. |
Description |
|
99.1 |
Press release dated January 6,
2004. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
GENEREX BIOTECHNOLOGY CORPORATION |
|
|
|
|
Dated: January 6,
2004 |
/s/ Rose C. Perri |
|
|
|
Rose C. Perri |
|
Chief Operating Officer |
|
(principal financial officer) |
Exhibit Index
Exhibit No. |
Description |
|
|
99.1 |
Press release dated January 6,
2004 |